Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference

Rhea-AI Summary

Clarus Therapeutics Holdings, Inc. (Nasdaq:CRXT) is set to present at the 2021 Cantor Virtual Global Healthcare Conference on September 27, 2021, at 10:40 a.m. ET. The presentation will focus on the company's commitment to addressing unmet medical needs through androgen and metabolic therapies. Investors can access the live webcast via the Investors section of the Clarus Therapeutics website, with an archived version available for 90 days post-presentation. Clarus's flagship product is JATENZO®, aimed at providing innovative solutions.

NORTHBROOK, Ill., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced that it will present at the 2021 Cantor Virtual Global Healthcare Conference, Monday, September 27, 2021, 10:40 a.m. ET.

The presentation will be webcast live and can be accessed through the Investors section of Clarus Therapeutics’ website at Investors.ClarusTherapeutics.com. An archived version of the webcast will be available approximately two hours following the live presentation for 90 days.

About Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women – including potential therapies for orphan indications. Clarus Therapeutics’ first commercial product is JATENZO®. For more information, visit www.clarustherapeutics.com and www.jatenzo.com. Follow us on Twitter (@Clarus_Thera) and LinkedIn (Clarus Therapeutics).

Clarus Investor Relations Contact:
Kara Stancell
kstancell@clarustherapeutics.com
(847) 562-4300 x 206

 

FAQ

When will Clarus Therapeutics present at the Cantor Virtual Global Healthcare Conference?

Clarus Therapeutics will present on September 27, 2021, at 10:40 a.m. ET.

What is the focus of Clarus Therapeutics' presentation at the conference?

The presentation will emphasize their androgen and metabolic therapies for unmet medical needs.

How can I access the Clarus Therapeutics conference presentation?

The presentation will be available via live webcast on the Investors section of their website.

What is Clarus Therapeutics' flagship product?

Clarus Therapeutics' first commercial product is JATENZO®.

Is the Clarus Therapeutics presentation available after it airs?

Yes, an archived version of the webcast will be available for 90 days after the live presentation.